Develops innovative products for the treatment of cardiovascular diseases
Industry Biotechnology
A.I.dvisor tells us that CAPR and CORT have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CAPR and CORT's prices will move in lockstep.
Ticker / NAME | Correlation To CAPR | 1D Price Change % | ||
---|---|---|---|---|
CAPR | 100% | +9.34% | ||
CORT - CAPR | 30% Poorly correlated | -2.94% | ||
KZR - CAPR | 29% Poorly correlated | -0.27% | ||
SNDX - CAPR | 27% Poorly correlated | +0.96% | ||
CARM - CAPR | 26% Poorly correlated | -3.52% | ||
ROIV - CAPR | 25% Poorly correlated | -2.59% | ||
More |
Ticker / NAME | Correlation To CAPR | 1D Price Change % |
---|---|---|
CAPR | 100% | +9.34% |
drugs theme (254 stocks) | 16% Poorly correlated | -4.03% |
cardiovascular theme (11 stocks) | 14% Poorly correlated | -2.10% |
biotechnology theme (238 stocks) | 12% Poorly correlated | -4.32% |
treatment theme (56 stocks) | 11% Poorly correlated | -4.29% |